Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -7.85% is 292% below its 5-year average of -2.00%, around the middle of its 5-year range (-32.64%–32.02%).
22.25% below its 12-month average of -6.42%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.69%.
OPERATING MARGIN
-7.85%
OPERATING MARGIN AVG TTM
-6.42%
OPERATING MARGIN AVG 3Y
-2.06%
OPERATING MARGIN AVG 5Y
-2.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-22.25%
CURRENT VS 3Y AVG
-280.26%
CURRENT VS 5Y AVG
-292.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
AirSculpt Technologies, Inc.
Market Cap
$134.74M
Operating Margin
-7.85%
TTM Avg
-6.42%
3Y Avg
-2.06%
5Y Avg
-2.00%
Market Cap
$138.26M
Operating Margin
-3.66%
TTM Avg
-13.20%
3Y Avg
-25.26%
5Y Avg
-22.69%
Market Cap
$130.05M
Operating Margin
-11.60%
TTM Avg
-17.18%
3Y Avg
-31.98%
5Y Avg
-39.70%
Market Cap
$129.14M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$128.24M
Operating Margin
-1853.92%
TTM Avg
-1829.87%
3Y Avg
-8864.53%
5Y Avg
-5959.13%
Market Cap
$142.11M
Operating Margin
-221.72%
TTM Avg
-110.86%
3Y Avg
-55.43%
5Y Avg
-36.95%
Market Cap
$142.49M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$143.81M
Operating Margin
-239.78%
TTM Avg
-210.59%
3Y Avg
-1665.90%
5Y Avg
-1977.59%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AirSculpt Technologies, Inc. (AIRS) | $134.74M | -7.85% | -6.42% | -2.06% | -2.00% |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | -3.66% | -13.20% | -25.26% | -22.69% |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | -11.60% | -17.18% | -31.98% | -39.70% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| Cibus, Inc. (CBUS)vs › | $128.24M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -221.72% | -110.86% | -55.43% | -36.95% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -111.00% | -151.19% | -184.89% | -203.40% |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | -239.78% | -210.59% | -1665.90% | -1977.59% |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
57.6%
Operating Margin
-7.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.69% |
| 2026-03-31 | -2.16% |
| 2025-12-31 | -4.56% |
| 2025-09-30 | -27.86% |
| 2025-06-30 | 1.79% |
| 2025-03-31 | -4.04% |
| 2024-12-31 | -10.54% |
| 2024-09-30 | -8.73% |
| 2024-06-30 | -9.77% |
| 2024-03-31 | 23.14% |
| 2023-12-31 | 2.95% |
| 2023-09-30 | 2.04% |
| 2023-06-30 | 9.63% |
| 2023-03-31 | 3.85% |
| 2022-12-31 | -14.65% |
| 2022-09-30 | -3.54% |
| 2022-06-30 | 7.98% |
| 2022-03-31 | -2.96% |
| 2021-12-31 | -32.64% |
| 2021-09-30 | 27.76% |
| 2021-06-30 | 32.02% |
| 2021-03-31 | 27.57% |
| 2020-12-31 | 27.34% |
| 2020-09-30 | 19.33% |
| 2020-06-30 | 1.53% |
| 2020-03-31 | 1.53% |
